title: [Prostatic cancer in the young adult].
abstract: Prostatic carcinoma is exceptional in young adults before the age of 30. It is often diagnosed at a late, clinically advanced stage with a poorly differentiated histological type. Treatment is usually palliative and the prognosis is very poor with a mean survival of 6 months. The authors report a new case in a 25-year-old patient with locally advanced poorly differentiated prostatic carcinoma and a Gleason score of 10 treated by endocrine therapy, radiotherapy and chemotherapy with a good clinical and radiological course with a follow-up of two years.
authors.affiliation: Service d'Urologie, Hôpital Charles Nicolle, Boulevard 9 avril, Tunis, Tunisie. m.sfaxi@caramail.com
authors.forename: Mohamed
authors.initials: M
authors.lastname: Sfaxi
authors.forename: Makram
authors.initials: M
authors.lastname: Miladi
authors.forename: Khaled
authors.initials: K
authors.lastname: Bacha
authors.forename: Rachida
authors.initials: R
authors.lastname: Zermani
authors.forename: Mohamed
authors.initials: M
authors.lastname: Chebil
authors.forename: Mohsen
authors.initials: M
authors.lastname: Ayed
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000532:radiotherapy; D000328:Adult; D000726:Androgen Antagonists; D003131:Combined Modality Therapy; D004961:Estramustine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D011879:Radiotherapy Dosage; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D004961:Estramustine